| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $136K | -86.8% |
| R&D Expense | $477.2M | +30.0% |
| SG&A Expense | $119.7M | +13.0% |
| Operating Income | -$596.8M | -26.4% |
| Pre-tax Income | -$607.9M | -18.5% |
| Income Tax | $129K | -7.2% |
| Net Income | -$608.0M | -18.5% |
| EPS (Basic) | -$0.87 | -10.1% |
| EPS (Diluted) | -$0.87 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $199.6M | -2.2% |
| Short-term Investments | $733.2M | -11.5% |
| Current Assets | $969.6M | -8.2% |
| Total Assets | $1.20B | -5.2% |
| Current Liabilities | $48.1M | +6.6% |
| Total Liabilities | $291.1M | +23.8% |
| Stockholders' Equity | $912.4M | -11.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$436.3M | -39.0% |
| Capital Expenditures | $40.6M | +32.7% |
| Investing Cash Flow | $70.8M | -11.9% |
| Financing Cash Flow | $361.1M | +25.3% |
| Free Cash Flow | -$476.9M | -38.5% |
| -10.1% |